ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm - first patient dosed in USA under FDA approved EAP
Published: 18/02/20, 09:12am (AEST)•3 pages